| 000 | 01584 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250512055630.0 | ||
| 264 | 0 | _c19860630 | |
| 008 | 198606s 0 0 eng d | ||
| 022 | _a0031-3955 | ||
| 024 | 7 |
_a10.1016/s0031-3955(16)36041-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStark, A R | |
| 245 | 0 | 0 |
_aRespiratory distress syndrome. _h[electronic resource] |
| 260 |
_bPediatric clinics of North America _cJun 1986 |
||
| 300 |
_a533-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCritical Care |
| 650 | 0 | 4 | _aDiuresis |
| 650 | 0 | 4 |
_aDiuretics _xtherapeutic use |
| 650 | 0 | 4 |
_aDuctus Arteriosus, Patent _xphysiopathology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibroblast Growth Factors _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aLung _xphysiopathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeuromuscular Blocking Agents _xtherapeutic use |
| 650 | 0 | 4 | _aOxygen Inhalation Therapy |
| 650 | 0 | 4 |
_aPhosphatidylcholines _xanalysis |
| 650 | 0 | 4 | _aPrenatal Diagnosis |
| 650 | 0 | 4 |
_aPulmonary Edema _xphysiopathology |
| 650 | 0 | 4 |
_aPulmonary Surfactants _xphysiology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aRespiration, Artificial _xmethods |
| 650 | 0 | 4 |
_aRespiratory Distress Syndrome, Newborn _xdiagnosis |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 |
_aSphingomyelins _xanalysis |
| 700 | 1 | _aFrantz, I D | |
| 773 | 0 |
_tPediatric clinics of North America _gvol. 33 _gno. 3 _gp. 533-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0031-3955(16)36041-2 _zAvailable from publisher's website |
| 999 |
_c3526185 _d3526185 |
||